Elsevier

Drug and Alcohol Dependence

Volume 43, Issue 3, 11 December 1996, Pages 119-124
Drug and Alcohol Dependence

Antisense confirmation of μ- and κ-opioid receptor mediation of morphine's effects on body temperature in rats

https://doi.org/10.1016/S0376-8716(96)01295-1Get rights and content

Abstract

Previous studies showed that parenterally administered morphine at 4–16 mg/kg markedly increased body temperature in the rat, but higher doses of morphine (>- 30 mg/kg, subcutaneously, sc) caused a profound decrease in body temperature. Based on the use of selective opioid agonists and antagonists, we postulated that these effects were due to morphine's actions on μ and κ receptors, respectively. In the present study, we sought to determine whether an antisense (AS) oligodeoxynucleotide (oligo) against cloned μ or κ opioid receptors could affect morphine-induced body temperature changes. AS oligos were directed against nucleotides 1–18 of the coding region of the μ receptor and 4–21 of the coding region of the κ receptor. Male SD rats were surgically implanted with intracerebroventricular (icv) cannulae. Rats received icv injections of vehicle or oligo in the animal colony room on days 1, 3 and 5. Either AS oligo or missense (MS) oligo was infused in a volume of 5 μl over 30 s to freely moving animals. On day 6, the rats were tested. The results showed that icv treatment with an AS oligo against μ opioid receptors, but not an MS oligo against the μ opioid receptor or an AS oligo against the κ opioid receptor, significantly attenuated the hyperthermia normally produced by a relatively low dose of morphine administered sc. In addition, treatment with an AS oligo against κ receptors, but not an MS oligo against κ opioid receptor or an AS oligo against the μ opioid receptor, significantly blocked the hypothermia induced by a high dose of morphine. This study confirms our earlier postulate that morphine at 4 mg/kg, sc, induces an increase in body temperature primarily via μ opioid receptors in the brain and a high dose (30 mg/kg) of morphine administered sc produces a decrease primarily through κ opioid receptors in the brain.

References (36)

  • G. Rossi et al.

    Blockade of morphine analgesia by an antisense oligodeoxynucleotide against the μ receptor

    Life Sci

    (1994)
  • G. Rossi et al.

    Antisense mapping the MOR-1 opioid receptor: evidence for alternative splicing and a novel morphine-6β-glucuronide receptor

    FEBS Letters

    (1995)
  • K.M. Standifer et al.

    Selective loss of δ opioid analgesia and binding by antisense oligodeoxynucleotides to a δ opioid receptor

    Neuron

    (1994)
  • F.S. Tepperman et al.

    Effect of intrahypothalamic injection of [D-Ala2,D-Leu5]enkephalin on feeding and temperature in the rat

    Eur. J. Pharmacol.

    (1983)
  • L.F. Tseng et al.

    Antisense oligodeoxynucleotide to a δ -opioid receptor selectively blocks the spinal antinociception induced by δ-, but not μ- or κ-opioid receptor agonists in the mouse

    Eur. J. Pharmacol.

    (1994)
  • C. Wahlestedt

    Antisense oligonucleotide strategies in neuropharmacology

    TiPS

    (1994)
  • J.U. Adams et al.

    Isobolographic superadditivity between delta and μ opioid agonists in the rat depends on the ratio of compounds, the μ agonist and the analgesic assay used

    J. Pharmacol. Exp. Ther.

    (1993)
  • J.U. Adams et al.

    Functional effect of antisense oligodeoxynucleotides to opioid receptors in rats

  • Cited by (25)

    • Excessive sweating following intrathecal μ agonists: Effective atropine management

      2016, Egyptian Journal of Anaesthesia
      Citation Excerpt :

      Experimentally, IT Mo has a biphasic thermal pattern. That high doses produce hypothermia by κ-opioid receptors stimulation [51], while the low doses produce hyperthermia by μ-opioid receptors activation, increasing thermoregulatory set point, oxygen consumption and peripheral vasoconstriction [52]. This hyperthermia is maximum at 2–3 h after subcutaneous morphine in rats [53].

    • Opioidergic projections to sleep-active neurons in the ventrolateral preoptic nucleus

      2008, Brain Research
      Citation Excerpt :

      In parallel with the sleep–wake response to morphine, low doses of morphine (4–16 mg/kg, i.v) induce hyperthermia, whereas high doses (> 30 mg/kg, i.v) produce hypothermia (Martin and Morrison, 1978). Chen et al. (1996) previously showed that icv injection of antisense oligodeoxynucleotide against the mu receptor (nucleotides 1–18 of the coding region of the mu receptor) prevented morphine-induced hyperthermia, and icv injection of an antisense oligodeoxynucleotide against kappa receptors (4–21 of the coding region of the kappa receptor) blocked morphine-induced hypothermia. These blocking effects were later replicated by microdialysis of antisense oligodeoxynucleotides for mu and kappa opioid receptors into the preoptic area (Xin et al., 1997).

    • Agmatine blocks morphine-evoked hyperthermia in rats

      2007, Brain Research
      Citation Excerpt :

      The effect of agmatine was blocked by idazoxan, suggesting a significant role for imidazoline receptors. Because low doses of morphine produce hyperthermia by activating mu receptors (Chen et al., 1996; Geller et al., 1983; Rawls et al., 2003; Spencer et al., 1988), these data support the existence of mu opioid–imidazoline receptor interactions and reveal that these interactions regulate morphine-evoked hyperthermia. Animal use procedures were conducted in strict accordance with the NIH Guide for the Care and Use of Laboratory Animals.

    • PKC and PKA inhibitors reverse tolerance to morphine-induced hypothermia and supraspinal analgesia in mice

      2004, European Journal of Pharmacology
      Citation Excerpt :

      For example, morphine-induced hypothermia in mice is mediated through composite actions on mu, delta and kappa opioid receptors, based on the ability of selective opioid receptor antagonists to block hypothermia (Baker and Meert, 2002). In rats, antisense oligodeoxynucleotide to kappa opioid receptors blocked the hypothermic effects of high (i.e., 30 mg/kg) doses of morphine (Chen et al., 1996). Thus, morphine-induced hypothermia may be mediated through multiple opioid receptor subtypes, especially at higher doses.

    View all citing articles on Scopus
    View full text